Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Nomogram for Preoperative Prediction of Adjuvant Therapy Requirement Following Radical Surgery in Stage IB Cervical Squamous Cell Carcinoma With Tumor Size ≤ 4 cm: A Retrospective Study.

Cancer medicine·2026
Same author

[Influence of nutritional composition and digestibility of different oat products on their glycemic index].

Wei sheng yan jiu = Journal of hygiene research·2026
Same author

Nanopore sequencing with proteins: synchronization and dischronization of molecular dynamics simulations with laboratory and industrial developments.

Soft matter·2026
Same author

NanoporeDB: A Structural Resource Of Multimeric Protein Nanopores For Single-Molecule Sensing.

GigaScience·2026
Same author

The skull bone marrow-meninges-brain axis: A new sentinel for neuroinflammation regulation in ischemic stroke.

Experimental neurology·2026
Same author

Precision glycoengineered AAV capsids enhance hepatocyte targeting and attenuated immune activation for liver-directed gene therapy.

Biomaterials·2026

Related Experiment Video

Updated: Apr 22, 2026

Generation and Expansion of Primary, Malignant Pleural Mesothelioma Tumor Lines
08:01

Generation and Expansion of Primary, Malignant Pleural Mesothelioma Tumor Lines

Published on: April 21, 2022

1.6K

Predictive factors analysis for malignant peritoneal mesothelioma.

Shi Jin1, Shoubo Cao, Jingyan Cao

  • 1Department of Medical Oncology, Harbin Medical University Cancer Hospital, No. 150 Haping Road, Harbin, 150081, China.

Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract
|October 10, 2014
PubMed
Summary

Malignant peritoneal mesothelioma (MPM) survival is improved in patients aged ≤65 years with abdominal pain who receive cytoreductive surgery plus adjuvant therapy. These factors independently predict better outcomes for MPM patients.

More Related Videos

Implantation and Monitoring by PET/CT of an Orthotopic Model of Human Pleural Mesothelioma in Athymic Mice
07:54

Implantation and Monitoring by PET/CT of an Orthotopic Model of Human Pleural Mesothelioma in Athymic Mice

Published on: December 21, 2019

6.3K
Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

1.0K

Related Experiment Videos

Last Updated: Apr 22, 2026

Generation and Expansion of Primary, Malignant Pleural Mesothelioma Tumor Lines
08:01

Generation and Expansion of Primary, Malignant Pleural Mesothelioma Tumor Lines

Published on: April 21, 2022

1.6K
Implantation and Monitoring by PET/CT of an Orthotopic Model of Human Pleural Mesothelioma in Athymic Mice
07:54

Implantation and Monitoring by PET/CT of an Orthotopic Model of Human Pleural Mesothelioma in Athymic Mice

Published on: December 21, 2019

6.3K
Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

1.0K

Area of Science:

  • Oncology
  • Surgical Oncology
  • Medical Oncology

Background:

  • Malignant peritoneal mesothelioma (MPM) is a rare cancer with poor prognosis and poorly understood natural history.
  • This study investigates prognostic factors and management strategies for MPM.

Purpose of the Study:

  • To identify independent prognostic factors for malignant peritoneal mesothelioma (MPM).
  • To evaluate the impact of treatment strategies on MPM patient survival.

Main Methods:

  • Retrospective review of clinical records for 39 MPM patients (2003-2014).
  • Overall survival analyzed using Kaplan-Meier curves and Cox regression.
  • Prognostic factors assessed through univariate and multivariate analyses.

Main Results:

  • Median survival was 10.0 months; 2-year survival rate was 15.8%.
  • Key clinical presentations included abdominal distension, pain, and weight loss.
  • Laboratory and CT scan findings indicated ascites, peritoneal masses, and thickening.
  • Cytoreductive surgery (CRS) plus adjuvant therapy was associated with improved survival compared to chemotherapy or best supportive care.

Conclusions:

  • Age ≤65 years, presence of abdominal pain, and undergoing CRS plus adjuvant therapy are independent positive prognostic factors for MPM.
  • These findings can inform treatment decisions and patient counseling for MPM.